United States· US:24478-106_32c90701-fe4a-4d5a-b3bb-e9ccf0416ece
DYANAVEL XR
A amfetamine product containing amphetamine, registered in United States by NextWave Pharmaceuticals, Inc. The same ATC class is registered in 3 of our 19 countries.
Checked against FDA National Drug Code directory (United States) on
Informational only — not a medical device.
Where it is registered
Amfetamine is registered in 3 of 19 countries.
Countries holding a registration under ATC N06BA01 (amfetamine), each read from that country’s own register.
- This record: United States, from FDA National Drug Code directory (United States)
- 2 of them publish a price we can compare per daily dose
Amfetamine · ATC N06BA01
3 / 19 countries
- Canada
- Norwayprice
- United Statesprice
The record
At a glance
FDA National Drug Code directory (United States)- Active substance
- AMPHETAMINE
- Manufacturer
- NextWave Pharmaceuticals, Inc
- Country
- United States (US)
- ATC code
- N06BA01
- ATC class
- Amfetamine
- Defined daily dose
- 15 mg, O
- Reimbursed
- Not published by this register
- Source register
- FDA National Drug Code directory (United States)
- Last checked
- September 27, 2026
Packs & prices · 2
- ndc1124478-106-01
- ndc11244781060130 TABLET, EXTENDED RELEASE in 1 BOTTLE (24478-106-01)
Regulatory notes
No shortage, Orange Book or US label notes for this record.
Interactions
132 interactions on record for amfetamine.
Graded by severity as the source publishes them — 16 severe. Severity grades are free for everyone; mechanism and management come with Growth.
- Severity for every pair — free, no plan needed
- The source, licence and sync date on every record
- Mechanism and what to do for each pair — Growth plan
Amfetamine · interactions on record
132 records
- 16 severe
- 100 moderate
- 16 info
Most severe, free to view
- FenfluramineA08AA02severe
- DexfenfluramineA08AA04severe
- SibutramineA08AA10severe
- ProcarbazineL01XB01severe
- Interaction severity from DDInter 2.0 (Xiong G. et al., Nucleic Acids Res.), licensed CC BY-NC 4.0 — free for non-commercial use only; not covered by the Drug Database commercial licence.
Same medicine, other countries
Amfetamine in 2 other countries
What each register calls a product with the same active substance — salts and hydrates count as the same.
Sourced from a public register and reproduced with attribution. Drug Database is not affiliated with, endorsed by, or a partner of FDA National Drug Code directory (United States). This is an informational data service and not a medical device — verify against the official source of record before any clinical decision.
For developers
The same record over the API, and the raw payload
GET /v1/drugs/d5237e45-ceb4-452b-ad59-f1dc6012149e GET /v1/drugs/d5237e45-ceb4-452b-ad59-f1dc6012149e?format=fhir
Every response carries last_synced_at, so freshness is a field rather than a promise. Below is exactly what the ingestion wrote, before any presentation — the same JSON the API returns under payload.
{
"route": "ORAL",
"source": "ndc",
"strength": "5",
"substance": "AMPHETAMINE",
"productndc": "24478-106",
"dosage_form": "TABLET, EXTENDED RELEASE",
"dea_schedule": "CII",
"strength_unit": "mg/1",
"application_number": "NDA210526",
"marketing_category": "NDA"
}See everything about amfetamine.
This page is the registration. A free account adds the label text as the regulator wrote it, what it costs per daily dose across the markets that publish a price, a feed of what changes in the registers, and an assistant that answers with its sources. Interaction severity is free; mechanism and management are on the Growth plan. No card, nothing to install.